Wockhardt Balance Sheet Health
Financial Health criteria checks 4/6
Wockhardt has a total shareholder equity of ₹34.3B and total debt of ₹22.7B, which brings its debt-to-equity ratio to 66.3%. Its total assets and total liabilities are ₹74.2B and ₹39.9B respectively.
Key information
66.3%
Debt to equity ratio
₹22.74b
Debt
Interest coverage ratio | n/a |
Cash | ₹1.15b |
Equity | ₹34.32b |
Total liabilities | ₹39.88b |
Total assets | ₹74.20b |
Recent financial health updates
Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?
Jun 23Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jan 04Recent updates
Subdued Growth No Barrier To Wockhardt Limited (NSE:WOCKPHARMA) With Shares Advancing 29%
Feb 21There's Reason For Concern Over Wockhardt Limited's (NSE:WOCKPHARMA) Massive 28% Price Jump
Dec 19There's No Escaping Wockhardt Limited's (NSE:WOCKPHARMA) Muted Revenues
Oct 14Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?
Jun 23Estimating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)
Feb 18Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jan 04Shareholders Will Probably Hold Off On Increasing Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation For The Time Being
Jul 26Calculating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)
May 18Calculating The Fair Value Of Wockhardt Limited (NSE:WOCKPHARMA)
Jan 26What Did Wockhardt's (NSE:WOCKPHARMA) CEO Take Home Last Year?
Dec 01Financial Position Analysis
Short Term Liabilities: WOCKPHARMA's short term assets (₹20.4B) do not cover its short term liabilities (₹26.9B).
Long Term Liabilities: WOCKPHARMA's short term assets (₹20.4B) exceed its long term liabilities (₹13.0B).
Debt to Equity History and Analysis
Debt Level: WOCKPHARMA's net debt to equity ratio (62.9%) is considered high.
Reducing Debt: WOCKPHARMA's debt to equity ratio has reduced from 131.9% to 66.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable WOCKPHARMA has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: WOCKPHARMA is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 1% per year.